{"id":30820,"date":"2022-12-16T10:46:11","date_gmt":"2022-12-16T11:46:11","guid":{"rendered":"https:\/\/peymantaeidi.net\/stem-cell\/?p=30820"},"modified":"2022-12-16T12:37:12","modified_gmt":"2022-12-16T12:37:12","slug":"local-startup-nanomatronix-receives-1-1-million-small-business-award","status":"publish","type":"post","link":"https:\/\/peymantaeidi.net\/stem-cell\/2022\/12\/16\/local-startup-nanomatronix-receives-1-1-million-small-business-award\/","title":{"rendered":"Local Startup Nanomatronix Receives $1.1 Million Small Business Award"},"content":{"rendered":"<div class=\"articleHead clearfix\">\n<p>\nDec. 16, 2022\n                    <\/p>\n<\/p><\/div>\n<div id=\"storyImagePanel\" class=\"col-sm-12 col-md-6 pull-right\">\n<p>                            <a href=\"https:\/\/peymantaeidi.net\/stem-cell\/wp-content\/uploads\/2022\/12\/2022-12-15_04-00-38-PMKartikBalachandraninhislab2.jpg\"><br \/>\n                                    <img decoding=\"async\" class=\"img-responsive\" src=\"https:\/\/peymantaeidi.net\/stem-cell\/wp-content\/uploads\/2022\/12\/2022-12-15_04-00-38-PMKartikBalachandraninhislab2.jpg\" alt=\"Kartik Balachandran\" width=\"100%\" \/><\/p>\n<p>                            <\/a><\/p>\n<div class=\"nwArticleCaption\">\n                                <span class=\"text-right nwPhotoCaption\">Photo by University Relations<\/span><\/p>\n<p>Kartik Balachandran<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<p>Nanomatronix, a local startup company that develops nanotechnology, microelectronics and biotechnology to provide solutions for the healthcare, energy and defense industries, has been awarded a $1.1 million&nbsp;<a href=\"https:\/\/www.sbir.gov\/\">Small Business Innovation and Research<\/a>&nbsp;Phase II Award from the Department of Defense. This award builds on a previous award from the department.<\/p>\n<p>The purpose of the award is to continue development of the Advanced Microphysiological Brain Injury Technology (or AMBIT) Platform. This is an organ-on-chip model that utilizes human, cell-based tissues to replicate brain injury pathophysiologies. The chip will enable researchers to model the transport of molecules across the blood-brain barrier before and after traumatic brain injury and examine the communication between different cell types,&nbsp;providing a useful tool for drug screening and toxicity studies.<\/p>\n<p>Kartik Balachandran, associate professor of biomedical engineering at the U of A, has been overseeing the research and development of the AMBIT Platform and has received a sub-award of $550,000.&nbsp;<\/p>\n<p>\u201cWe\u2019re excited for the opportunity to further develop our AMBIT Platform towards commercialization&nbsp;and also expand our customer base,\u201d Balachandran said.<\/p>\n<p>\u201cNanomatronix is excited to collaborate with Dr. Kartik Balachandran to bring AMBIT to market,\u201d said Angeline Rodriguez, a biomedical engineer who will oversee the grant at Nanomatronix. \u201cThe goal of this Phase II project is completion of a viable product and service. Additional evolutionary product improvements are being identified, currently, through the NSF STTR Program. In approximately two to two and a half years, the first full AMBIT product will be ready for launch, and the first batch of products will be delivered to customers.\u201d<\/p>\n<p>Rodriguez added that what made AMBIT unique was that previously developed brain-chips do not have the ability to mechanically mimic traumatic brain injury in their design.&nbsp;<\/p>\n<p>\u201cAMBIT is able to provide a TBI-like mechanical insult to study its effects on the blood-brain barrier,\u201d Rodriguez said. \u201cThis platform is relevant for drug discovery and testing in the context of TBI-mediated pathologies and other neurotrauma sequelae. AMBIT is designed using iPSC-derived cells, so it will play an important role in precision medicine because the cellular components can be derived from patient-specific, clinical-grade cells.\u201d&nbsp;<\/p>\n<p>Rodriguez noted that organ-on-chip technology was revolutionizing the study of diseases, and that Balachandran\u2019s work presented a&nbsp;unique business opportunity to explore technology that can be used to evaluate brain injury pathophysiology.<\/p>\n<p>The federal&nbsp;<a href=\"https:\/\/www.sbir.gov\/\">Small Business Innovation and Research<\/a>&nbsp;award program incentivizes small businesses to pursue research and development with the potential for commercialization. The goal is for businesses to reach their technological potential and to create a pathway to profitability through commercialization.<\/p>\n<p>Those interested in Balachandran\u2019s organ-on-chip research, which can replicate a range of organs, can find a fuller treatment on the U of A\u2019s&nbsp;<a href=\"https:\/\/determined.uark.edu\/deconstructing-the-body.php\">Determined<\/a>&nbsp;website.<\/p>\n<p><strong>About the University of Arkansas:<\/strong>&nbsp;As Arkansas&#8217; flagship institution, the U&nbsp;of&nbsp;A provides an internationally competitive education in more than 200 academic programs. Founded in 1871, the U&nbsp;of&nbsp;A contributes more than&nbsp;<a href=\"https:\/\/www.uark.edu\/about\/economic-impact\/index.php\" target=\"_blank\" rel=\"noopener\">$2.2 billion to Arkansas\u2019 economy<\/a>&nbsp;through the teaching of new knowledge and skills, entrepreneurship and job development, discovery through research and creative activity while also providing training for professional disciplines. The Carnegie Foundation classifies the U&nbsp;of&nbsp;A among the few U.S. colleges and universities with the highest level of research activity.&nbsp;<em>U.S. News &amp; World Report&nbsp;<\/em>ranks the U&nbsp;of&nbsp;A among the top public universities in the nation. See how the U\u202fof\u202fA works to build a better world at&nbsp;<a href=\"https:\/\/arkansasresearch.uark.edu\/\" target=\"_blank\" rel=\"noopener\">Arkansas Research News<\/a>.<\/p>\n<p>                <span class=\"clearfix\"><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dec. 16, 2022 Photo by University Relations Kartik Balachandran Nanomatronix, a local startup company that<\/p>\n","protected":false},"author":1,"featured_media":30822,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/30820"}],"collection":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/comments?post=30820"}],"version-history":[{"count":2,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/30820\/revisions"}],"predecessor-version":[{"id":30823,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/posts\/30820\/revisions\/30823"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media\/30822"}],"wp:attachment":[{"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/media?parent=30820"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/categories?post=30820"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/peymantaeidi.net\/stem-cell\/wp-json\/wp\/v2\/tags?post=30820"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}